Brief: Taro Pharmaceutical Launches Specialty Generic Deferiprone Tablets, 500Mg In U.S.
Sept 28 (Reuters) - Taro Pharmaceutical Industries Ltd
TARO.N :
* TARO PHARMACEUTICAL INDUSTRIES LTD - LAUNCHES SPECIALTY
GENERIC
DEFERIPRONE TABLETS, 500MG IN U.S.
Source text for Eikon: ID:nBw1y9W1ma
Further company coverage: TARO.N
((reuters.briefs@thomsonreuters.com;))
Recent news on Taro Pharmaceutical Industries
See all newsBrief: Taro Pharmaceutical Industries Says Taro Shareholders Approve Merger With Sun Pharma
Taro Pharmaceutical Industries Ltd reports results for the quarter ended in March - Earnings Summary
Taro Pharmaceutical Industries Ltd expected to post earnings of 31 cents a share - Earnings Preview
Ex-Sandoz exec gets probation for price-fixing after cooperation deal
Brief: ISS, Glass Lewis Recommend Taro Shareholders Vote For Merger With Sun Pharma